DERMALIBOUR+ BARRIER
Barrier cream
DERMALIBOUR+ BARRIER Cream isolates, protects and soothes irritated skin.
Its targeted “second-skin” effect texture protects skin against cold, water, friction, chemicals, detergent solutions and contact with irritant metals in the workplace and at home.
Formulated to last for 5 baths* (in freshwater, seawater or chlorinated water).
A care product that combines efficacy and safety, thanks to a fragrance-free formula, for use on the face, hands and body from birth.
* Study carried out on 16 subjects in freshwater and 16 subjects in chlorinated water. Measurement of lipid index.
-
For whom?From birthChildrenAdults
-
Price50 mL€10 to €12100 mL€15 to €17
-
Texture“Second-skin” effectEnveloping texture when spreadLeaves a soft, powdery finish
Patient relations
-
Application tips
If necessary, first cleanse skin with DERMALIBOUR+ Foaming CICA-gel, then apply once or twice to the area of skin you want to protect before exposure to external damage and before swimming.
Ingredients
Active ingredients:
Triple anti-inflammatory activity for anti-itching, anti-irritation and anti-redness efficacy.
Sanitizing, thanks to its bacteriostatic and fungistatic action, it limits the risk of bacterial proliferation.
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Efficacy results
Immediate reduction in the sum of physical signs (erythema, edema, desquamation and dryness) and functional signs (burning, pruritus, tightness and tingling) (1)
Skin is repaired and protected (% satisfaction) (3)
Skin is soothed (% satisfaction) (3)
Tolerance results
Good skin tolerance in 83 subjects (infants, children, adults) after application for 21 days. (1)
Excellent gynecological tolerance in 42 subjects (seniors) after application for 21 days (2)
Legal Notice
(1) Tolerance and efficacy study of DERMALIBOUR+ BARRIER Soothing barrier cream carried out under dermatological and ophthalmological control on 83 subjects with irritant contact dermatitis. At least 2 applications per day for 21 days.
(2) Tolerance study of DERMALIBOUR+ BARRIER Soothing barrier cream carried out under dermatological and ophthalmological control on 42 incontinent seniors. At least 2 applications per day for 21 days.
(3) Tolerance and perceived efficacy study (%) after use on 42 (adult) subjects with work-related hand irritation. At least 2 applications per day for 21 days.
Discover the range
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Have you noticed any side effects?
The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.